|  | Survival probabilitiesa |  | ||
---|---|---|---|---|---|
 | All ( n = 1,488) | 3 days | 7 days | 28 days | P value (log-rank test) |
Age (years) | Â | Â | Â | Â | Â |
   <60 | 428 (28.8%) | 86.0% | 79.9% | 67.8% | <0.0001 |
   60 to <70 | 277 (25.3%) | 82.2% | 74.8% | 57.8% |  |
   70 to <80 | 437 (29.4%) | 80.3% | 75.0% | 54.1% |  |
   ≥80 | 246 (16.5%) | 78.0% | 71.1% | 45.7% |  |
Gender | Â | Â | Â | Â | Â |
   Female | 537 (36.1%) | 82.7% | 76.7% | 61.6% | 0.04 |
   Male | 951 (63.9%) | 81.7% | 75.2% | 55.4% |  |
BMI (kg/m²) |  |  |  |  |  |
   <20 | 129 (8.7%) | 81.4% | 74.4% | 55.5% | 0.06 |
   20-25 | 371 (24.9%) | 83.0% | 77.0% | 56.4% |  |
   25-30 | 388 (26.1%) | 82.0% | 77.8% | 59.0% |  |
   >30 | 336 (22.6%) | 85.7% | 79.1% | 61.4% |  |
   N/A | 264 (17.7%) |  |  |  |  |
Co-morbiditiesb | Â | Â | Â | Â | Â |
   Immunosuppressionc | 459 (30.9%) | 76.7% | 66.6% | 44.9% | <0.0001 |
Cancer (solid tumors) | 226 (49.2%) | 77.9% | 68.4% | 44.5% | 0.97 |
Hematological cancer | 142 (30.9%) | 69.0% | 57.0% | 37.0% | <0.01 |
Corticoids | 109 (23.8%) | 79.8% | 71.6% | 52.9% | 0.55 |
Transplantation | 40 (8.7) | 82.5% | 77.5% | 55.0% | 0.15 |
AIDS | 10 (2.2%) | 80.0% | 70.0% | 30.0% | 0.63 |
Other | 77 (16.8%) | 74.0% | 64.0% | 48.0% | 0.90 |
   Diabetes mellitus | 387 (26.0%) | 84.7% | 77.7% | 55.8% | 0.63 |
   Cirrhosis | 133 (8.9%) | 79.7% | 66.8% | 41.7% | <0.0001 |
   Chronic heart failure (NYHA Class III/IV) | 160 (10.8%) | 78.1% | 72.5% | 46.1% | <0.01 |
   Chronic respiratory failurec | 113 (7.6%) | 86.7% | 81.4% | 57.9% | 0.80 |
   Chronic renal failured | 171 (11.6%) | 81.5% | 75.7% | 49.4% | 0.04 |
Number of co-morbidities | Â | Â | Â | Â | Â |
   None | 510 (34.3%) | 85.5% | 81.4% | 70.0% | <0.0001 |
   1 | 633 (42.5%) | 80.1% | 73.1% | 54.7% |  |
   2 or more | 339 (23.1%) | 80.6% | 72.1% | 44.7% |  |
Knausc | Â | Â | Â | Â | Â |
   A/B | 853 (57.4%) | 85.5% | 80.3% | 65.0% | <0.0001 |
   C/D | 634 (42.6%) | 77.4% | 69.5% | 47.6% |  |
SOFA | Â | Â | Â | Â | Â |
   ≥11 | 823 (55.3%) | 72.5% | 65.6% | 45.0% | <0.0001 |
   <11 | 665 (44.7%) | 93.8% | 88.3% | 73.3% |  |
SAPS II | Â | Â | Â | Â | Â |
   ≥56 | 753 (50.6%) | 69.3% | 61.3% | 40.9% | <0.0001 |
   <56 | 735 (49.4%) | 95.1% | 90.4% | 74.8% |  |
Site of infectionb | Â | Â | Â | Â | Â |
   Respiratory tract | 798 (53.6%) | 84.1% | 77.4% | 56.7% | 0.84 |
   Abdominal | 285 (19.2%) | 83.1% | 75.0% | 58.2% | 0.83 |
   Renal/urinary tract | 209 (14.1%) | 86.6% | 82.8% | 69.5% | <0.001 |
   Bloodstream | 196 (13.2%) | 70.4% | 63.3% | 49.8% | <0.001 |
   Other | 88 (5.9%) | 81.8% | 75.0% | 57.3% | 0.99 |
Type of infection | Â | Â | Â | Â | Â |
   Community-acquired | 974 (65.5%) | 82.6% | 78.1% | 61.9% | <0.0001 |
   Nosocomial | 514 (34.5%) | 80.9% | 71.2% | 49.6% |  |
Germ identification | Â | Â | Â | Â | Â |
   Yes | 1,000 (67.2%) | 81.8% | 75.9% | 58.8% | 0.21 |
   No | 488 (32.8%) | 82.6% | 75.4% | 55.2% |  |
Type of admission | Â | Â | Â | Â | Â |
   Planned surgery | 37 (2.5%) | 89.2% | 83.8% | 64.2% | <0.01 |
   Medical | 1,248 (83.9%) | 80.7% | 74.2% | 55.9% |  |
   Emergency surgery | 203 (13.6%) | 89.2% | 83.2% | 67.3% |  |
Origin of patient | 595 (40.0%) | Â | Â | Â | Â |
   Home | 23 (1.6%) | 84.0% | 79.1% | 65.3% | <0.0001 |
   Nursing home | 870 (58.5%) | 95.6% | 91.3% | 73.9% |  |
   Transfer |  | 80.3% | 73.0% | 51.9% |  |